Tech Company Financing Transactions

Kolltan Pharmaceuticals Funding Round

Kolltan Pharmaceuticals, based in New Haven, raised $35 million from private investors.

Transaction Overview

Announced On
1/9/2009
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series A
Investors
Proceeds Purpose
The proceeds of the Series A financing will be used to advance Kolltan's therapeutic development pipeline.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 George St. 530
New Haven, CT 06511
USA
Email Address
Overview
Kolltan is a development-stage company advancing therapeutics that target well-defined and validated molecular mechanisms of disease in areas of critical clinical need.
Profile
Kolltan Pharmaceuticals LinkedIn Company Profile
Social Media
Kolltan Pharmaceuticals Company Twitter Account
Company News
Kolltan Pharmaceuticals News
Facebook
Kolltan Pharmaceuticals on Facebook
YouTube
Kolltan Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gerald McMahon
  Gerald McMahon LinkedIn Profile  Gerald McMahon Twitter Account  Gerald McMahon News  Gerald McMahon on Facebook
Chief Medical Officer
Ronald Peck
  Ronald Peck LinkedIn Profile  Ronald Peck Twitter Account  Ronald Peck News  Ronald Peck on Facebook
VP - Product Management
Theresa LaVallee
  Theresa LaVallee LinkedIn Profile  Theresa LaVallee Twitter Account  Theresa LaVallee News  Theresa LaVallee on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/8/2009: Aptus Endosystems venture capital transaction
Next: 1/9/2009: StreamBase Systems venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary